Low-Dose Naltrexone HSA/FSA Eligibility and Submission

What Is Low-Dose Naltrexone and Why Does Cost Matter?

Low-dose naltrexone refers to naltrexone HCl formulated at doses of 1.5 to 4.5 mg, far below the FDA-approved 50 mg dose used in opioid and alcohol use disorder. Naltrexone at 50 mg received FDA approval in 1984; the low-dose variant is prepared by 503A compounding pharmacies under individual prescriptions and is used off-label for conditions ranging from fibromyalgia and multiple sclerosis to Crohn disease and autoimmune disorders.

The Compounding Pharmacy Context

Because LDN is not commercially manufactured at these low doses, patients must obtain it from a 503A compounding pharmacy. The FDA distinguishes between 503A pharmacies (patient-specific) and 503B outsourcing facilities; a 2023 FDA guidance document outlines the regulatory framework for both. Compounded drugs are not FDA-approved finished drug products, which affects both insurance coverage and how HSA/FSA administrators categorize reimbursement claims. FDA guidance on compounding describes these distinctions in detail.

Why Standard Insurance Rarely Covers LDN

Most commercial health plans deny LDN claims as "not medically necessary" or "investigational." A 2021 systematic review published on PubMed examining LDN in inflammatory conditions found promising signals but noted that randomized controlled trial evidence remains limited, which is precisely the evidentiary threshold most payers require before covering a therapy. Without formulary coverage, cash pay at a compounding pharmacy runs $30, $80 per month, making pre-tax accounts the most practical cost-reduction tool available to most patients.

Does Low-Dose Naltrexone Qualify for HSA/FSA?

Yes. Compounded LDN qualifies as an HSA/FSA-eligible medical expense under IRS Internal Revenue Code §213(d), provided it is prescribed by a licensed clinician to treat or mitigate a specific diagnosed medical condition. The IRS definition of a qualifying medical expense does not require FDA approval; it requires that the expense be incurred "for the diagnosis, cure, mitigation, treatment, or prevention of disease." IRS Publication 502 (2025 edition) lists prescription drugs, including compounded preparations, as eligible.

The IRS §213(d) Standard

Section 213(d) of the Internal Revenue Code is the controlling statute. It reads, in relevant part, that a medical care expense includes "amounts paid for the diagnosis, cure, mitigation, treatment, or prevention of disease, or for the purpose of affecting any structure or function of the body." Because LDN is obtained by prescription and used to treat a diagnosed condition, it satisfies this standard. The key word is "prescription." Over-the-counter naltrexone does not exist, so every LDN transaction automatically has a prescription attached, clearing the first eligibility hurdle.

Why a Letter of Medical Necessity Strengthens Your Claim

A Letter of Medical Necessity (LMN) is a signed statement from your prescriber explaining the diagnosis, why LDN is an appropriate treatment, and why a commercially available drug is not substituted. Most HSA/FSA plan administrators accept compounded drug claims without an LMN when the prescription receipt is clear. However, some third-party administrators flag compounded medications for additional review. Submitting an LMN proactively reduces the chance of denial and speeds reimbursement. The American Academy of Family Physicians outlines documentation standards for prescriptions and medical necessity in its clinical documentation guidelines.

Eligible Conditions Commonly Treated With LDN

The IRS does not publish a condition-by-condition list; eligibility turns on whether a physician has diagnosed a specific condition and prescribed LDN to address it. Conditions for which LDN is most often prescribed off-label include fibromyalgia, Crohn disease, multiple sclerosis, and a range of autoimmune disorders. A 2018 pilot trial in fibromyalgia (N=31) reported a 30% reduction in pain scores with LDN versus placebo, published in PAIN. A 2011 pilot study in Crohn disease (N=40) found that 88% of participants receiving LDN showed a significant response versus 40% on placebo (P<0.001), per PubMed. Each of these diagnoses supports a valid LMN.

How to Submit an LDN Claim to Your HSA or FSA

The submission process has four steps. Get the prescription filled at a 503A compounding pharmacy. Obtain an itemized receipt. Request an LMN from your prescriber if your administrator requires one. Submit through your plan's portal or by mail.

Step 1. Fill the Prescription and Collect Documentation

Ask the compounding pharmacy for an itemized receipt that shows the patient name, drug name (naltrexone), strength (e.g., 4.5 mg capsules), quantity dispensed, date of service, and total amount paid. This receipt is your primary substantiation document. The IRS requires substantiation records to be kept for at least three years after the filing date of the return for which the deduction is claimed, per IRS Publication 502.

Step 2. Request a Letter of Medical Necessity

Your HealthRX prescriber can generate a standard LMN that includes your diagnosis (ICD-10 code), the prescribed dose, the expected duration of therapy, and a brief clinical rationale. A well-drafted LMN reads something like this:

"Patient carries a diagnosis of fibromyalgia (ICD-10: M79.3) and has had an inadequate response to duloxetine 60 mg and pregabalin 150 mg. Low-dose naltrexone 4.5 mg nightly is prescribed based on pilot RCT evidence suggesting modulation of microglial activation. A commercially available equivalent does not exist at this dose."

This type of language directly addresses every element that HSA/FSA administrators look for when reviewing compounded drug claims.

Step 3. Submit to Your Plan Administrator

Most plans accept claims online. Log in to your HSA or FSA administrator's portal (examples include HealthEquity, Optum Bank, WEX Health, Wageworks/TASC) and upload the itemized receipt. If your administrator requests additional documentation, attach the LMN as a PDF. Processing time is typically 3 to 10 business days. Keep copies of everything for three years. For FSA accounts specifically, confirm your plan year end date and any grace period or rollover provisions, because unspent FSA funds are forfeited under the "use-it-or-lose-it" rule codified in IRS Notice 2005-86.

Step 4. If Your Claim Is Denied

Denials for compounded drugs are usually administrative, not regulatory. Common reasons include missing drug name on the receipt, missing prescription number, or absence of an LMN. Submit an appeal with the corrected documentation. The Employee Benefits Security Administration (EBSA) under the Department of Labor oversees FSA claim disputes for employer-sponsored plans; their claims and appeals guidance describes your rights. HSA disputes are governed by your custodian agreement and ultimately by the IRS.

How Much Can You Actually Save?

The savings calculation is straightforward. LDN at $60/month costs $720 per year. Funded through an HSA or FSA using pre-tax dollars, the effective cost depends on your marginal federal tax rate.

At the 22% bracket: $720 x (1 - 0.22) = $561.60 effective cost, saving $158.40 per year. At the 32% bracket: $720 x (1 - 0.32) = $489.60 effective cost, saving $230.40 per year.

State income tax adds further savings in most states. A 2024 Kaiser Family Foundation report found that the average FSA-enrolled employee saves approximately $800 per year across all FSA-eligible expenses by using pre-tax dollars, per KFF analysis data cited in CMS documentation.

2026 HSA Contribution Limits

The IRS increased HSA limits for 2026 in Revenue Procedure 2025-19. The individual contribution limit is $4,300 and the family limit is $8,550. To contribute to an HSA you must be enrolled in a High Deductible Health Plan (HDHP). The minimum HDHP deductible for 2026 is $1,650 (individual) and $3,300 (family), per IRS Rev. Proc. 2025-19.

FSA vs. HSA: Which Is Better for LDN?

Both accounts work for LDN reimbursement. The practical difference is that FSA funds must be spent within the plan year (or a grace period of up to 2.5 months, or a $640 rollover if your employer opts in under IRS Notice 2013-71). HSA funds roll over indefinitely and can be invested. For a patient taking LDN continuously, an HSA is superior because you can accumulate funds and reimburse yourself retroactively for any expense incurred after the HSA was established, without a deadline. The IRS permits reimbursement of prior-year expenses from an HSA as long as the expense occurred after the account opening date, per IRS Publication 969.

Other Ways to Get Low-Dose Naltrexone Cheaper

HSA/FSA is one tool. Several others can be stacked with it or used independently.

Compounding Pharmacy Shopping

503A compounding pharmacy pricing for LDN varies widely. A 90-capsule supply of LDN 4.5 mg can range from $30 at a high-volume compounding pharmacy to $90 at a lower-volume local pharmacy. Ask for the cash price explicitly; some pharmacies list higher "retail" prices and discount upon request. The FDA's webpage on human drug compounding provides a list of considerations when choosing a 503A pharmacy, including state licensure verification.

GoodRx and Discount Cards

GoodRx and similar discount programs apply to FDA-approved commercial drugs dispensed at retail pharmacies. Because LDN is compounded rather than a commercial product, GoodRx typically does not apply. However, if a prescriber writes for standard 50 mg naltrexone tablets and the pharmacy divides the tablets (a practice sometimes used but generally not recommended due to inconsistent dosing), GoodRx prices for naltrexone 50 mg can be as low as $15, $25 for 30 tablets at major chains. Splitting is not clinically validated. A 2013 pharmacokinetic study found that plasma naltrexone levels vary significantly with tablet division, published in the Journal of Clinical Pharmacology, making compounded capsules the preferred form for precise low-dose delivery.

HealthRX Membership and Bundled Pricing

HealthRX members may access bundled consultation-plus-prescription pricing that reduces the total monthly cost of LDN therapy compared to paying separately for telehealth visits and pharmacy fills. Consult the HealthRX pricing page for current rates; programs change frequently and figures published here may not reflect the most current offers.

Patient Assistance and Copay Programs

Because LDN is compounded and not a branded product, manufacturer patient assistance programs do not apply. Some compounding pharmacies offer loyalty discounts for 90-day supplies. Paying quarterly rather than monthly can reduce the per-capsule cost by 10 to 15% at many pharmacies.

The Clinical Evidence Base for LDN: Why Payers Hesitate

Understanding why insurance companies deny LDN claims helps patients build a stronger LMN and set realistic expectations.

Fibromyalgia

A 2013 crossover pilot RCT (N=31) published in PAIN found LDN 4.5 mg produced a statistically significant 30% reduction in pain scores compared to placebo, with average daily pain reduced by 1.14 points on a 10-point scale (P<0.05), per PubMed. The study was small. Payers require phase III trial data before routine coverage, which LDN lacks for any indication at the low-dose range.

Crohn Disease

A 2011 randomized pilot trial (N=40) found that 88% of pediatric patients receiving LDN 0.1 mg/kg showed a clinical response versus 40% on placebo (P<0.001), per PubMed. A 2018 Cochrane-adjacent systematic review of LDN in inflammatory bowel disease concluded that "larger, well-designed RCTs are needed before LDN can be recommended for routine use," per PubMed. That language is precisely why payers classify LDN as investigational.

Multiple Sclerosis

A randomized, double-blind, placebo-controlled trial of LDN in primary progressive MS (N=96) found no significant difference in the primary outcome of fatigue, though quality-of-life measures showed modest improvement, published in JAMA Neurology and indexed on PubMed. The FDA has not approved naltrexone for MS at any dose.

What This Means for Your LMN

The LMN should acknowledge the off-label status, cite the available pilot evidence, document prior treatment failures, and explain why LDN is a reasonable next step for the individual patient. A prescriber who documents these elements satisfies the IRS §213(d) standard even if the drug lacks FDA approval for the specific condition. IRS Publication 502 explicitly states that expenses for drugs obtained by prescription qualify regardless of FDA approval status for the claimed use, provided they are prescribed by a licensed clinician.

Documentation Checklist Before You Submit

Keep all of these for at least three years after the tax year in which you claim the expense:

• Itemized pharmacy receipt with drug name, strength, quantity, date, and cost
• Copy of the prescription (some administrators require this)
• Letter of Medical Necessity signed by your prescriber
• Confirmation of HSA/FSA submission and approval
• Bank or account statements showing the reimbursement deposit

The IRS may audit HSA distributions. Under IRS Publication 969, distributions from an HSA used for non-qualifying expenses are subject to income tax plus a 20% excise penalty for individuals under age 65. Solid documentation eliminates that risk entirely.

Special Situations

Dependents and Spouses

HSA and FSA funds can reimburse qualifying medical expenses for the account holder, their spouse, and tax dependents as defined under IRC §152, per IRS Publication 969. If your spouse or dependent has been prescribed LDN, the same rules apply.

Retired Individuals (HSA After Age 65)

After age 65, HSA distributions for non-qualifying expenses are taxed as ordinary income but no longer carry the 20% penalty. LDN remains a qualifying expense at any age, so retirees can reimburse LDN from their HSA without any penalty or special consideration beyond normal income tax rules, per IRS Publication 969.

HDHP Enrollment Requirement for HSA Contributions

You can only contribute new money to an HSA while enrolled in a qualifying HDHP. However, if you contributed to an HSA in prior years, you can still reimburse current LDN expenses from accumulated HSA funds even if you are no longer HDHP-enrolled. The HDHP requirement applies to contributions, not distributions. IRS Publication 969 clarifies this distinction.

Flexible Spending Account Timing Rule

FSA funds are available on day one of the plan year, even before contributions are fully made, for medical care FSAs. This means you can fill a 90-day LDN supply in January and submit the claim immediately, even if your payroll contributions will not cover the full amount until later in the year, per IRS Rev. Rul. 2003-43.